Smithfield Trust’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $285K | Sell |
3,954
-832
| -17% | -$64.1K | 0.01% | 316 |
|
|
2025
Q4 | $380K | Sell |
4,786
-65
| -1% | -$5.12K | 0.02% | 271 |
|
|
2025
Q3 | $367K | Sell |
4,851
-20
| -0.4% | -$1.37K | 0.02% | 266 |
|
|
2025
Q2 | $336K | Hold |
4,871
| – | – | 0.02% | 273 |
|
|
2025
Q1 | $331K | Sell |
4,871
-319
| -6% | -$19.1K | 0.02% | 259 |
|
|
2024
Q4 | $232K | Sell |
5,190
-214
| -4% | -$12K | 0.01% | 314 |
|
|
2024
Q3 | $340K | Sell |
5,404
-1,799
| -25% | -$105K | 0.02% | 266 |
|
|
2024
Q2 | $425K | Sell |
7,203
-158
| -2% | -$9.88K | 0.02% | 218 |
|
|
2024
Q1 | $590K | Sell |
7,361
-1,588
| -18% | -$121K | 0.03% | 193 |
|
|
2023
Q4 | $708K | Sell |
8,949
-118
| -1% | -$8.4K | 0.04% | 169 |
|
|
2023
Q3 | $634K | Sell |
9,067
-8
| -0.1% | -$567 | 0.04% | 165 |
|
|
2023
Q2 | $624K | Buy |
9,075
+196
| +2% | +$13.9K | 0.04% | 173 |
|
|
2023
Q1 | $658K | Sell |
8,879
-86
| -1% | -$7.21K | 0.04% | 159 |
|
|
2022
Q4 | $836K | Hold |
8,965
| – | – | 0.06% | 138 |
|
|
2022
Q3 | $851K | Sell |
8,965
-78
| -0.9% | -$7.72K | 0.06% | 128 |
|
|
2022
Q2 | $841K | Sell |
9,043
-10
| -0.1% | -$976 | 0.06% | 134 |
|
|
2022
Q1 | $916K | Buy |
9,053
+840
| +10% | +$88.2K | 0.06% | 135 |
|
|
2021
Q4 | $846K | Sell |
8,213
-18
| -0.2% | -$1.66K | 0.05% | 150 |
|
|
2021
Q3 | $698K | Sell |
8,231
-4
| -0% | -$335 | 0.05% | 160 |
|
|
2021
Q2 | $687K | Sell |
8,235
-122
| -1% | -$9.99K | 0.05% | 160 |
|
|
2021
Q1 | $629K | Buy |
8,357
+462
| +6% | +$33.7K | 0.04% | 165 |
|
|
2020
Q4 | $540K | Buy |
7,895
+758
| +11% | +$49.3K | 0.04% | 170 |
|
|
2020
Q3 | $417K | Sell |
7,137
-1,052
| -13% | -$65.5K | 0.03% | 184 |
|
|
2020
Q2 | $532K | Buy |
8,189
+1,914
| +31% | +$121K | 0.05% | 158 |
|
|
2020
Q1 | $372K | Sell |
6,275
-910
| -13% | -$60.7K | 0.04% | 167 |
|
|
2019
Q4 | $534K | Buy |
7,185
+40
| +0.6% | +$2.81K | 0.05% | 160 |
|
|
2019
Q3 | $451K | Sell |
7,145
-1,694
| -19% | -$100K | 0.04% | 172 |
|
|
2019
Q2 | $482K | Buy |
8,839
+85
| +1% | +$4.58K | 0.05% | 163 |
|
|
2019
Q1 | $472K | Sell |
8,754
-757
| -8% | -$46.7K | 0.05% | 160 |
|
|
2018
Q4 | $623K | Sell |
9,511
-13
| -0.1% | -$970 | 0.07% | 127 |
|
|
2018
Q3 | $750K | Sell |
9,524
-118
| -1% | -$8.44K | 0.08% | 126 |
|
|
2018
Q2 | $620K | Buy |
9,642
+2,610
| +37% | +$172K | 0.07% | 133 |
|
|
2018
Q1 | $438K | Sell |
7,032
-589
| -8% | -$42.3K | 0.05% | 171 |
|
|
2017
Q4 | $553K | Buy |
7,621
+912
| +14% | +$66.3K | 0.07% | 157 |
|
|
2017
Q3 | $545K | Buy |
6,709
+609
| +10% | +$48.2K | 0.07% | 147 |
|
|
2017
Q2 | $491K | Hold |
6,100
| – | – | 0.07% | 152 |
|
|
2017
Q1 | $479K | Sell |
6,100
-2,512
| -29% | -$201K | 0.08% | 154 |
|
|
2016
Q4 | $679K | Sell |
8,612
-2,424
| -22% | -$196K | 0.11% | 117 |
|
|
2016
Q3 | $982K | Sell |
11,036
-14
| -0.1% | -$1.32K | 0.18% | 76 |
|
|
2016
Q2 | $1.06M | Sell |
11,050
-41
| -0.4% | -$4.09K | 0.2% | 72 |
|
|
2016
Q1 | $1.15M | Buy |
11,091
+2,495
| +29% | +$243K | 0.22% | 63 |
|
|
2015
Q4 | $840K | Sell |
8,596
-48
| -0.6% | -$4.7K | 0.17% | 83 |
|
|
2015
Q3 | $834K | Sell |
8,644
-111
| -1% | -$11.7K | 0.18% | 83 |
|
|
2015
Q2 | $918K | Sell |
8,755
-221
| -2% | -$22.6K | 0.18% | 86 |
|
|
2015
Q1 | $926K | Sell |
8,976
-70
| -0.8% | -$7.08K | 0.18% | 87 |
|
|
2014
Q4 | $872K | Sell |
9,046
-16
| -0.2% | -$1.41K | 0.18% | 91 |
|
|
2014
Q3 | $721K | Sell |
9,062
-1,503
| -14% | -$118K | 0.15% | 114 |
|
|
2014
Q2 | $797K | Sell |
10,565
-278
| -3% | -$21K | 0.16% | 113 |
|
|
2014
Q1 | $812K | Sell |
10,843
-694
| -6% | -$49K | 0.16% | 111 |
|
|
2013
Q4 | $826K | Buy |
11,537
+276
| +2% | +$17.7K | 0.17% | 109 |
|
|
2013
Q3 | $639K | Sell |
11,261
-4,316
| -28% | -$257K | 0.15% | 118 |
|
|
2013
Q2 | $891K | Buy |
+15,577
| New | +$902K | 0.21% | 98 |
|
Other funds holding CVS
VCM
VPM
Smithfield Trust's CVS Position: Q1 2026 in Review
Smithfield Trust reduced its CVS Health (CVS) stake by 17% in Q1 2026, selling an estimated $64.1K and leaving 3,954 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #316.
Smithfield Trust first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.15M in Q1 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Smithfield Trust held 3,954 shares of CVS Health worth $285K as of Q1 2026.
- Smithfield Trust sold 832 CVS Health shares in Q1 2026, an estimated $64.1K.
- CVS Health made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #316 holding.
- Smithfield Trust first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Smithfield Trust's CVS Health position peaked at $1.15M in Q1 2016.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.